Episode Details
Back to Episodes
SF Healthcare Week: Soleno Therapeutics' Chairman & CEO Anish Bhatnager discusses the launch of its Prader-Willi syndrome therapy VYKAT XR
Published 8 months ago
Description
He describes the launch, physician and patient feedback, and responds in his own words to short seller criticism.